30 August 2024
QV Bioelectronics secures £343,000 from Innovate UK’s Cancer Therapeutics programme to develop a new treatment for childhood brain tumours.
Press Release The project will adapt QV Bioelectronics’ existing electric field therapy (EFT) technology to develop the world’s first fully implantable EFT device to treat…
24 October 2023
QV Bioelectronics and Incubate Bio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma
Collaboration delivered vital insights to advance revolutionary treatment modality – GRACE ALaSCA platform able to decipher experimental data from complex molecular pathways and simulate ‘what-if’…
10 July 2023
Michaela Joins QV as Summer Intern
Exciting News: Welcome Michaela Baek, Our New Summer Intern at QV Bioelectronics! ? Michaela, an aspiring biologist, is eager to dive into the world of…
7 June 2023
QV Bioelectronics selected for TMC inaugural UK cohort
QV Bioelectronics are one of 16 leading digital health and medical device startups founded in the UK have been selected for a customized accelerator at…
31 March 2023
Press Release: QV Bioelectronics Awarded £860,000 Innovate UK Boost.
QV Bioelectronics Awarded £860,000 Innovate UK Boost. Funds awarded under Combined Investor Partnerships by Innovate UK, the UK’s innovation agency. The funds will facilitate critical…
27 January 2023
Kashmeera Koh joins the Team as Biomedical Engineer.
Hire #3 of 2023 joins the QV Bioelectronics team! ?? We are delighted to announce that Kashmeera Koh has joined QV as a Biomedical Engineer. ?? Kashmeera…
23 January 2023
Tomisin Olukoga joins QV as Scientist, Cancer Biology
The team keeps on growing! ? We’re delighted to announce the arrival of Tomisin in the role of Scientist, Cancer Biology ?? Tomisin is a cell biologist…
23 January 2023
Douglas Venters Joins QV as Senior Project Engineer
Welcome to the newest Team Member! ?? Douglas Venters Delighted to announce Doug is joining the QV Bioelectronics team as a Senior Project Engineer. ⚙️ Doug is…
10 January 2023
QV Bioelectronics Raises £2m to Develop Revolutionary Electric Field Therapy Implant for Brain Tumour Treatment
10th January 2022, Cheshire, UK £2M Pre-Series A financing raised from new and existing VCs. The funds will facilitate the completion of pre-clinical studies and the…
8 August 2022
Sabine Ficek Joins QV Bio as new CFO
We are delighted to announce that Sabine Ficek has joined our growing team QV Bioelectronics as CFO! Sabine is a seasoned CFO with 25 years of experience within Finance…
1 June 2022
QV Bioelectronics CEO Dr Chris Bullock Gives Evidence as an Industry Expert to the All-Party Parliamentary Group on Brain Tumours (APPGBT)
The All-Party Parliamentary Group on Brain Tumours (APPGBT) held a fifth oral evidence session today as part of its ongoing inquiry, Pathway to a Cure – breaking down…
4 February 2022
QV Bioelectronics Awarded £630,000 Under Innovate UK Biomedical Catalyst Award for implanted electric field therapy device for brain cancer treatment.
Funding will accelerate development of the GRACE implant to treat brain tumour patients with electric field therapy. The project will accelerate the collection of…
Interested in Receiving our Press Releases?